Science Explorer Back to mapMap
Discussion
Researcher · Yale University · United States

Lieping Chen

Lieping Chen publishes mostly in Immunology, Oncology and Molecular Biology, on topics such as Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers and Immune Cell Function and Interaction.

ORCID 0000-0002-6825-3069 OpenAlex
World rank
#18,091
of 7,710,434 ranked researchers
Rank in United States
#6,498
of 1,627,098
Works
677
Citations
97k
Citations per work
142.7
h-index
133
i10-index 345Top 0.1% in Immunology
Lieping Chen

What does Lieping Chen research?

Lieping Chen's work is mostly in Immunology and Microbiology (47%), Medicine (32%), Biochemistry, Genetics and Molecular Biology (4%).

Life Sciences: 345 works · 50.9% of their workImmunology and Microbiology: 319 works · 47.1% of their workImmunology: 319 works · 47.1% of their workBiochemistry, Genetics and Molecular Biology: 26 works · 3.8% of their workMolecular Biology: 26 works · 3.8% of their workHealth Sciences: 214 works · 31.6% of their workMedicine: 214 works · 31.6% of their workOncology: 164 works · 24.2% of their workPulmonary and Respiratory Medicine: 19 works · 2.8% of their workRadiology, Nuclear Medicine and Imaging: 19 works · 2.8% of their workSurgery: 12 works · 1.8% of their workEverything else: 118 works · 17.5% of their workTHEIR WORKLieping Chen677works
Life Sciences51%Health Sciences32%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology31947.1%
    2. Biochemistry, Genetics and Molecular Biology263.8%
    1. Medicine21431.6%
  3. Everything else11817.5%
  1. 1Immunology47% of their works
  2. 2Oncology24% of their works
  3. 3Molecular Biology4% of their works
  4. 4Radiology, Nuclear Medicine and Imaging3% of their works
  5. 5Pulmonary and Respiratory Medicine3% of their works
  6. 6Surgery2% of their works

Research topics

Which keywords describe Lieping Chen's research?

The keywords of their largest research topics: Cancer Immunotherapy, Immunity, Antigen Presentation, Dendritic Cells, Immune Checkpoint Blockade, PD-1 and PD-L1, Natural Killer Cells and NK Cell Recognition.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Cancer Immunotherapy3582 topics
  2. Immunity2782 topics
  3. Antigen Presentation2511 topic
  4. Dendritic Cells2511 topic
  5. Immune Checkpoint Blockade1861 topic
  6. PD-1 and PD-L11861 topic
  7. NK Cell Recognition1811 topic
  8. Natural Killer Cells1811 topic
  9. Foxp31321 topic
  10. TGF-ß1321 topic
  11. CAR T Cells1071 topic
  12. Chimeric Antigen Receptor1071 topic
  13. Inflammation572 topics
  14. Pattern Recognition Receptors301 topic
  15. Toll-like Receptors301 topic
  16. Activation271 topic
  17. Fc Receptors271 topic
  18. Macrophage271 topic
  19. Therapeutic Antibodies271 topic

Where does Lieping Chen work?

Lieping Chen's main affiliation in the publication record is Yale University, United States.

How many publications and citations does Lieping Chen have?

OpenAlex counts 677 works and 96,626 citations for Lieping Chen, an h-index of 133, ranking #18,091 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Lieping Chen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.